Heat Biologics Inc. (HTBX) Declined -8.17% or -0.03 To Price $0.38 On Friday


Heat Biologics Inc. (HTBX) declined -8.17% or -0.03 to $0.38. It is around 500000 shares traded, which is 82.92% compare to the average total volume 603013. The market cap of HTBX is $13.67 million. The year to date change is -52.24%. The 52 week price range is from $0.3 to $1.25. Price of HTBX have changed 3.60% during last week. It have changed -13.37% over last month, -40.87% over last 3 months, -34.64% over last 6 months and -59.80% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for HTBX is 0.50. It is 31.58% above current price. The 200-day Moving Averages for HTBX is 0.62. It is 63.16% above current price. The 52-week High is 1.25. It is 228.95% from the current price. The 52-week Low is 0.3. It is -21.05% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of HTBX is 2.05 on 2017-11-30. Short % to float is 2.42%. There are some statistics of HTBX. It is has market cap $13.67 million. The share outstanding is 35.79 million. The average volume is 603013. The revenue is 1.03M. The percent of top 15 Institution holding is 2.90%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of HTBX is -162.24%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of HTBX is -99.40%.


Tags:

Share this post